XML 43 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings per Share Data
6 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings per Share Data
Note 5
Earnings per Share Data
The Condensed Consolidated Financial Statements include basic and diluted earnings per share information. The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended March 31, 2020 and 2019:
 
   Quarter Ended March 31,   Six Months Ended March 31, 
   2020   2019   2020   2019 
Net Income (Loss)
  $(655,000  $7,460,000   $1,834,000   $7,773,000 
  
 
 
   
 
 
   
 
 
   
 
 
 
Common Shares:
        
Weighted average common shares outstanding
   14,586,000    14,541,000    14,586,000    14,541,000 
Effect of dilutive stock options
   —      167,000    128,000    164,000 
  
 
 
   
 
 
   
 
 
   
 
 
 
Diluted shares outstanding
   14,586,000    14,708,000    14,714,000    14,705,000 
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic:
        
Net earnings (loss) per share
  $(0.04  $0.51   $0.13   $0.53 
  
 
 
   
 
 
   
 
 
   
 
 
 
Diluted:
        
Net earnings (loss) per share
  $(0.04  $0.51   $0.12   $0.53 
  
 
 
   
 
 
   
 
 
   
 
 
 
Basic earnings per share is based on the weighted-average number of shares outstanding. Diluted earnings per share is based on the sum of the weighted-average number of shares outstanding plus common stock equivalents.
For the quarter ended March 31, 2020, there w
ere
no common stock equivalents included in the diluted earnings per share calculation. The weighted-average shares issuable upon the exercise of stock options included in the diluted earnings per share calculation for the six months ended March 31, 2020 were 260,000, which equates to 128,000 dilutive common stock equivalents. There were 30,000 weighted-average shares issuable upon the exercise of stock options, which were not included in the diluted earnings per share calculation for the six months ended March 31, 2020 because they were anti-dilutive. The weighted-average shares issuable upon the exercise of stock options included in the diluted earnings per share calculation for the quarter and six months ended March 31, 2019 were 317,000 and 317,000, respectively, which equates to 167,000 and 164,000 dilutive common stock equivalents, respectively. There were no anti-dilutive shares for the quarter and six months ended March 31, 2019.